Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis

BACKGROUND: Several randomized controlled trials (RCTs) have confirmed the favorable clinical benefit of pembrolizumab in advanced non-small cell lung cancer (NSCLC). However, considering the strict inclusion and exclusion criteria in clinical research, there are certain differences between patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Beibei, Wang, Bing, Chen, Yongbang, Wan, Ning, Xie, Fei, Yang, Ning, Lu, Liqing, Xiao, Weibin, Yuan, Jin, Li, Jian, Xie, Bo, Ji, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942927/
https://www.ncbi.nlm.nih.gov/pubmed/36824127
http://dx.doi.org/10.3389/fonc.2023.1044327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942927/
https://www.ncbi.nlm.nih.gov/pubmed/36824127
http://dx.doi.org/10.3389/fonc.2023.1044327

Ejemplares similares